secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001640334-25-001240
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences enters $6.5M at-the-market equity offering with R.F. Lafferty
--------------------------------------------------------------------------------

- Agreement with R.F. Lafferty & Co. to sell up to $6.5M of common stock via ATM program.
- Manager commission: 2.0% of gross sales price per share; Company may set minimum price.
- Offering can be suspended by either party on 5 days' notice; Company has no obligation to sell.
- Based on existing Form S-3 shelf effective July 14, 2023; prospectus supplement filed July 18, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001240/0001640334-25-001240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001240/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-001240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer